Total Payments
$12,662
2024 Payments
$4,874
Companies
24
Transactions
522
Medicare Patients
1,201
Medicare Billing
$93,729
Payment Breakdown by Category
Food & Beverage$10,312 (81.4%)
Consulting$2,110 (16.7%)
Education$239.97 (1.9%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $10,312 | 517 | 81.4% |
| Consulting Fee | $2,110 | 2 | 16.7% |
| Education | $239.97 | 3 | 1.9% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| GENZYME CORPORATION | $2,291 | 47 | $0 (2024) |
| ABBVIE INC. | $2,179 | 97 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $1,108 | 59 | $0 (2024) |
| Verrica Pharmaceuticals Inc. | $1,024 | 2 | $0 (2024) |
| Dermavant Sciences, Inc. | $1,001 | 81 | $0 (2024) |
| Amgen Inc. | $943.11 | 55 | $0 (2024) |
| LEO Pharma Inc. | $937.42 | 37 | $0 (2024) |
| Lilly USA, LLC | $681.47 | 31 | $0 (2024) |
| PFIZER INC. | $560.25 | 38 | $0 (2024) |
| Incyte Corporation | $305.25 | 14 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $4,874 | 150 | GENZYME CORPORATION ($1,398) |
| 2023 | $2,903 | 146 | ABBVIE INC. ($591.73) |
| 2022 | $2,702 | 115 | ABBVIE INC. ($881.19) |
| 2021 | $2,183 | 111 | AbbVie Inc. ($507.85) |
All Payment Transactions
522 individual payment records from CMS Open Payments — Page 1 of 21
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/30/2024 | Inspire Medical Systems, Inc. | INSPIRE (Device) | Food and Beverage | In-kind items and services | $27.21 | General |
| Category: NEUROLOGY | ||||||
| 12/18/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $19.30 | General |
| Category: Immunology | ||||||
| 12/17/2024 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $5.53 | General |
| Category: DERMATOLOGY | ||||||
| 12/17/2024 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $5.04 | General |
| Category: DERMATOLOGY | ||||||
| 12/16/2024 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $16.08 | General |
| Category: DERMATOLOGY | ||||||
| 12/13/2024 | LEO Pharma Inc. | ADBRY (Biological) | Food and Beverage | In-kind items and services | $19.55 | General |
| Category: DERMATOLOGY | ||||||
| 12/12/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $29.32 | General |
| Category: Immunology | ||||||
| 12/11/2024 | Lilly USA, LLC | EBGLYSS (Drug) | Food and Beverage | In-kind items and services | $20.90 | General |
| Category: Immunology | ||||||
| 12/10/2024 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $14.12 | General |
| Category: DERMATOLOGY | ||||||
| 12/06/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $27.35 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 12/05/2024 | Arcutis Biotherapeutics, Inc. | Zoryve (Drug) | Food and Beverage | In-kind items and services | $22.76 | General |
| Category: Dermatology | ||||||
| 12/04/2024 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $10.67 | General |
| Category: DERMATOLOGY | ||||||
| 12/04/2024 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $10.10 | General |
| Category: DERMATOLOGY | ||||||
| 12/03/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Consulting Fee | Cash or cash equivalent | $1,110.00 | General |
| Category: Immunology | ||||||
| 11/28/2024 | Journey Medical Corporation | — | Food and Beverage | In-kind items and services | $22.20 | General |
| 11/26/2024 | LEO Pharma Inc. | ADBRY (Biological) | Food and Beverage | In-kind items and services | $22.18 | General |
| Category: DERMATOLOGY | ||||||
| 11/22/2024 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $6.21 | General |
| Category: DERMATOLOGY | ||||||
| 11/22/2024 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $6.15 | General |
| Category: DERMATOLOGY | ||||||
| 11/22/2024 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $3.29 | General |
| Category: DERMATOLOGY | ||||||
| 11/21/2024 | Incyte Corporation | OPZELURA (Drug) | Food and Beverage | Cash or cash equivalent | $21.64 | General |
| Category: Dermatology | ||||||
| 11/18/2024 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $10.95 | General |
| Category: DERMATOLOGY | ||||||
| 11/18/2024 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $10.01 | General |
| Category: DERMATOLOGY | ||||||
| 11/14/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $30.21 | General |
| Category: Immunology | ||||||
| 11/14/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $8.35 | General |
| Category: IMMUNOLOGY | ||||||
| 11/11/2024 | Arcutis Biotherapeutics, Inc. | Zoryve (Drug) | Food and Beverage | In-kind items and services | $19.36 | General |
| Category: Dermatology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 8 | 249 | 416 | $97,187 | $18,156 |
| 2022 | 10 | 361 | 633 | $166,338 | $31,736 |
| 2021 | 8 | 257 | 517 | $107,715 | $22,632 |
| 2020 | 7 | 334 | 592 | $69,333 | $21,205 |
Total Patients
1,201
Total Services
2,158
Medicare Billing
$93,729
Procedure Codes
33
All Medicare Procedures & Services
33 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 67 | 105 | $28,713 | $5,824 | 20.3% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2023 | 31 | 39 | $13,647 | $2,944 | 21.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 26 | 32 | $12,362 | $2,307 | 18.7% |
| 17004 | Destruction of precancer skin growth, 15 or more growths | Office | 2023 | 11 | 19 | $9,821 | $2,060 | 21.0% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 41 | 41 | $13,808 | $1,867 | 13.5% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2023 | 31 | 36 | $11,228 | $1,845 | 16.4% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 22 | 25 | $5,149 | $748.30 | 14.5% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2023 | 20 | 119 | $2,460 | $559.00 | 22.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 76 | 132 | $36,732 | $7,113 | 19.4% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2022 | 49 | 73 | $25,882 | $5,114 | 19.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 33 | 52 | $20,479 | $4,155 | 20.3% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 55 | 55 | $18,787 | $3,611 | 19.2% |
| 17004 | Destruction of precancer skin growth, 15 or more growths | Office | 2022 | 19 | 35 | $18,355 | $3,452 | 18.8% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2022 | 36 | 46 | $14,793 | $2,467 | 16.7% |
| 17111 | Destruction of skin growth, 15 or more growths | Office | 2022 | 14 | 23 | $9,529 | $2,030 | 21.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 20 | 20 | $10,194 | $1,980 | 19.4% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2022 | 32 | 40 | $8,299 | $1,059 | 12.8% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2022 | 27 | 157 | $3,288 | $755.40 | 23.0% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 64 | 117 | $30,190 | $6,806 | 22.5% |
| 17110 | Destruction of up to 14 skin growths | Office | 2021 | 40 | 67 | $22,472 | $4,910 | 21.8% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 28 | 45 | $17,029 | $3,669 | 21.5% |
| 99203 | New patient outpatient visit, total time 30-44 minutes | Office | 2021 | 31 | 31 | $10,188 | $2,103 | 20.6% |
| 17000 | Destruction of skin growth | Office | 2021 | 32 | 52 | $10,196 | $1,577 | 15.5% |
| 11102 | Tangential biopsy of single skin lesion | Office | 2021 | 23 | 28 | $8,607 | $1,414 | 16.4% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 12 | 12 | $5,893 | $1,389 | 23.6% |
About Lillian Wang
Lillian Wang is a Physician Assistant healthcare provider based in Mesquite, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/17/2019. The National Provider Identifier (NPI) number assigned to this provider is 1710451372.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Lillian Wang has received a total of $12,662 in payments from pharmaceutical and medical device companies, with $4,874 received in 2024. These payments were reported across 522 transactions from 24 companies. The most common payment nature is "Food and Beverage" ($10,312).
As a Medicare-enrolled provider, Wang has provided services to 1,201 Medicare beneficiaries, totaling 2,158 services with total Medicare billing of $93,729. Data is available for 4 years (2020–2023), covering 33 distinct procedure/service records.
Ad
Practice Information
- Specialty Physician Assistant
- Location Mesquite, TX
- Active Since 01/17/2019
- Last Updated 01/17/2019
- Taxonomy Code 363A00000X
- Entity Type Individual
- NPI Number 1710451372
Products in Payments
- DUPIXENT (Biological) $3,299
- YCANTH (Drug) $1,024
- SKYRIZI (Biological) $1,006
- VTAMA (Drug) $1,001
- Otezla (Drug) $819.43
- RINVOQ (Biological) $751.83
- ADBRY (Biological) $684.54
- TALTZ (Drug) $539.19
- EUCRISA (Drug) $467.00
- OPZELURA (Drug) $305.25
- ENSTILAR (Drug) $229.18
- SPEVIGO (Drug) $227.04
- HUMIRA (Biological) $222.37
- Sotyktu (Drug) $182.65
- LIBTAYO (Biological) $129.79
- Enbrel (Biological) $123.68
- Zoryve (Drug) $99.20
- CIBINQO (Drug) $93.25
- Bimzelx (Biological) $69.32
- REMICADE (Biological) $34.37
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Physician Assistant Doctors in Mesquite
Wendy Fasano, Pa, PA
Physician Assistant — Payments: $9,677
Physician Assistant $9,677
Alexandra Hoeger
Physician Assistant — Payments: $7,237
Physician Assistant $7,237
Nathan Yeh
Physician Assistant — Payments: $4,236
Physician Assistant $4,236
Evan Conrad, Pa, PA
Physician Assistant — Payments: $4,026
Physician Assistant $4,026
Katherine Schultheiss, Pa, PA
Physician Assistant — Payments: $3,986
Physician Assistant $3,986
Gabriela Pina
Physician Assistant — Payments: $2,411
Physician Assistant $2,411